| Year |
Citation |
Score |
| 2023 |
Narayanan KK, Amaya M, Tsang N, Yin R, Jays A, Broder CC, Shukla D, Procko E. Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins. Journal of Virology. e0062123. PMID 37931130 DOI: 10.1128/jvi.00621-23 |
0.366 |
|
| 2023 |
Mastraccio KE, Huaman C, Coggins SA, Clouse C, Rader M, Yan L, Mandal P, Hussain I, Ahmed AE, Ho T, Feasley A, Vu BK, Smith IL, Markotter W, Weir DL, ... ... Broder CC, et al. mAb therapy controls CNS-resident lyssavirus infection via a CD4 T cell-dependent mechanism. Embo Molecular Medicine. e16394. PMID 37767784 DOI: 10.15252/emmm.202216394 |
0.424 |
|
| 2023 |
Huaman C, Paskey AC, Clouse C, Feasley A, Rader M, Rice GK, Luquette AE, Fitzpatrick MC, Drumm HM, Yan L, Cer RZ, Donduashvili M, Buchukuri T, Nanava A, Hulseberg CE, ... ... Broder CC, et al. Genomic Surveillance of Rabies Virus in Georgian Canines. Viruses. 15. PMID 37766204 DOI: 10.3390/v15091797 |
0.32 |
|
| 2023 |
Wang Z, McCallum M, Yan L, Sharkey W, Park YJ, Dang HV, Amaya M, Person A, Broder CC, Veesler DJ. Structure and design of Langya virus glycoprotein antigens. Biorxiv : the Preprint Server For Biology. PMID 37645760 DOI: 10.1101/2023.08.20.554025 |
0.406 |
|
| 2023 |
Amaya M, Broder CC, Laing ED. Recombinant Cedar Virus: A Henipavirus Reverse Genetics Platform. Methods in Molecular Biology (Clifton, N.J.). 2682: 73-86. PMID 37610574 DOI: 10.1007/978-1-0716-3283-3_5 |
0.444 |
|
| 2023 |
Yan L, Sterling SL, Fusco DL, Chan YP, Xu K, Laing ED, Broder CC. Recombinant Soluble Henipavirus Glycoprotein Preparation. Methods in Molecular Biology (Clifton, N.J.). 2682: 33-58. PMID 37610572 DOI: 10.1007/978-1-0716-3283-3_3 |
0.446 |
|
| 2023 |
Amaya M, Yin R, Yan L, Borisevich V, Adhikari BN, Bennett A, Malagon F, Cer RZ, Bishop-Lilly KA, Dimitrov AS, Cross RW, Geisbert TW, Broder CC. A Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay Platform for Pathogenic Henipaviruses. Viruses. 15. PMID 37243163 DOI: 10.3390/v15051077 |
0.42 |
|
| 2023 |
Chen WH, Hajduczki A, Martinez EJ, Bai H, Matz H, Hill TM, Lewitus E, Chang WC, Dawit L, Peterson CE, Rees PA, Ajayi AB, Golub ES, Swafford I, Dussupt V, ... ... Broder CC, et al. Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity. Nature Communications. 14: 580. PMID 36737435 DOI: 10.1038/s41467-023-36106-x |
0.305 |
|
| 2022 |
Wang Z, Dang HV, Amaya M, Xu Y, Yin R, Yan L, Hickey AC, Annand EJ, Horsburgh BA, Reid PA, Smith I, Eden JS, Xu K, Broder CC, Veesler D. Potent monoclonal antibody-mediated neutralization of a divergent Hendra virus variant. Proceedings of the National Academy of Sciences of the United States of America. 119: e2122769119. PMID 35617431 DOI: 10.1073/pnas.2122769119 |
0.338 |
|
| 2022 |
Pulscher LA, Peel AJ, Rose K, Welbergen JA, Baker ML, Boyd V, Low-Choy S, Edson D, Todd C, Dorrestein A, Hall J, Todd S, Broder CC, Yan L, Xu K, et al. Serological evidence of a pararubulavirus and a betacoronavirus in the geographically isolated Christmas Island flying-fox (Pteropus natalis). Transboundary and Emerging Diseases. PMID 35491954 DOI: 10.1111/tbed.14579 |
0.343 |
|
| 2022 |
Wang Z, Amaya M, Addetia A, Dang HV, Reggiano G, Yan L, Hickey AC, DiMaio F, Broder CC, Veesler D. Architecture and antigenicity of the Nipah virus attachment glycoprotein. Science (New York, N.Y.). eabm5561. PMID 35239409 DOI: 10.1126/science.abm5561 |
0.458 |
|
| 2022 |
Laing ED, Weiss CD, Samuels EC, Coggins SA, Wang W, Wang R, Vassell R, Sterling SL, Tso MS, Conner T, Goguet E, Moser M, Jackson-Thompson BM, Illinik L, Davies J, ... ... Broder CC, et al. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers. Emerging Infectious Diseases. 28. PMID 35203111 DOI: 10.3201/eid2804.212037 |
0.361 |
|
| 2022 |
Annand EJ, Horsburgh BA, Xu K, Reid PA, Poole B, de Kantzow MC, Brown N, Tweedie A, Michie M, Grewar JD, Jackson AE, Singanallur NB, Plain KM, Kim K, Tachedjian M, ... ... Broder CC, et al. Novel Hendra Virus Variant Detected by Sentinel Surveillance of Horses in Australia. Emerging Infectious Diseases. 28: 693-704. PMID 35202527 DOI: 10.3201/eid2803.211245 |
0.444 |
|
| 2021 |
Doyle MP, Kose N, Borisevich V, Binshtein E, Amaya M, Nagel M, Annand EJ, Armstrong E, Bombardi R, Dong J, Schey KL, Broder CC, Zeitlin L, Kuang EA, Bornholdt ZA, et al. Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding protein. Cell Reports. 36: 109628. PMID 34469726 DOI: 10.1016/j.celrep.2021.109628 |
0.459 |
|
| 2021 |
Ramos I, Goforth C, Soares-Schanoski A, Weir DL, Samuels EC, Phogat S, Meyer M, Huang K, Pietzsch CA, Ge Y, Pike BL, Regeimbal J, Simons MP, Termini MS, Vangeti S, ... ... Broder CC, et al. Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection. Frontiers in Immunology. 12: 681586. PMID 34177926 DOI: 10.3389/fimmu.2021.681586 |
0.316 |
|
| 2021 |
Pollett SD, Richard SA, Fries AC, Simons MP, Mende K, Lalani T, Lee T, Chi S, Mody R, Madar C, Ganesan A, Larson DT, Colombo CJ, Colombo R, Samuels EC, ... Broder CC, et al. The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 34117878 DOI: 10.1093/cid/ciab543 |
0.371 |
|
| 2021 |
Jackson-Thompson BM, Goguet E, Laing ED, Olsen CH, Pollett S, Hollis-Perry KM, Maiolatesi SE, Illinik L, Ramsey KF, Reyes AE, Alcorta Y, Wong MA, Davies J, Ortega O, Parmelee E, ... ... Broder CC, et al. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers. Bmc Infectious Diseases. 21: 544. PMID 34107889 DOI: 10.1186/s12879-021-06233-1 |
0.333 |
|
| 2021 |
Amaya M, Cheng H, Borisevich V, Navaratnarajah CK, Cattaneo R, Cooper L, Moore TW, Gaisina IN, Geisbert TW, Rong L, Broder CC. A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research. 105084. PMID 34077807 DOI: 10.1016/j.antiviral.2021.105084 |
0.371 |
|
| 2021 |
Dang HV, Cross RW, Borisevich V, Bornholdt ZA, West BR, Chan YP, Mire CE, Da Silva SC, Dimitrov AS, Yan L, Amaya M, Navaratnarajah CK, Zeitlin L, Geisbert TW, Broder CC, et al. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins. Nature Structural & Molecular Biology. PMID 33927387 DOI: 10.1038/s41594-021-00584-8 |
0.442 |
|
| 2021 |
Cheliout Da Silva S, Yan L, Dang HV, Xu K, Epstein JH, Veesler D, Broder CC. Functional Analysis of the Fusion and Attachment Glycoproteins of Mojiang Henipavirus. Viruses. 13. PMID 33809833 DOI: 10.3390/v13030517 |
0.418 |
|
| 2021 |
Weir DL, Coggins SA, Vu BK, Coertse J, Yan L, Smith IL, Laing ED, Markotter W, Broder CC, Schaefer BC. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses. Viruses. 13. PMID 33804519 DOI: 10.3390/v13030391 |
0.397 |
|
| 2021 |
Geisbert TW, Bobb K, Borisevich V, Geisbert JB, Agans KN, Cross RW, Prasad AN, Fenton KA, Yu H, Fouts TR, Broder CC, Dimitrov AS. A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus. Npj Vaccines. 6: 23. PMID 33558494 DOI: 10.1038/s41541-021-00284-w |
0.346 |
|
| 2020 |
Epstein JH, Anthony SJ, Islam A, Kilpatrick AM, Ali Khan S, Balkey MD, Ross N, Smith I, Zambrana-Torrelio C, Tao Y, Islam A, Quan PL, Olival KJ, Khan MSU, Gurley ES, ... ... Broder CC, et al. Nipah virus dynamics in bats and implications for spillover to humans. Proceedings of the National Academy of Sciences of the United States of America. PMID 33139552 DOI: 10.1073/pnas.2000429117 |
0.327 |
|
| 2020 |
Amaya M, Broder CC. Vaccines to Emerging Viruses: Nipah and Hendra. Annual Review of Virology. 7: 447-473. PMID 32991264 DOI: 10.1146/annurev-virology-021920-113833 |
0.43 |
|
| 2020 |
Gómez Román R, Wang LF, Lee B, Halpin K, de Wit E, Broder CC, Rahman M, Kristiansen P, Saville M. Nipah@20: Lessons Learned from Another Virus with Pandemic Potential. Msphere. 5. PMID 32641430 DOI: 10.1128/mSphere.00602-20 |
0.322 |
|
| 2020 |
Mastraccio KE, Huaman C, Warrilow D, Smith GA, Craig SB, Weir DL, Laing ED, Smith IL, Broder CC, Schaefer BC. Establishment of a longitudinal pre-clinical model of lyssavirus infection. Journal of Virological Methods. 113882. PMID 32407866 DOI: 10.1016/j.jviromet.2020.113882 |
0.359 |
|
| 2019 |
Prasad AN, Woolsey C, Geisbert JB, Agans KN, Borisevich V, Deer DJ, Mire CE, Cross RW, Fenton KA, Broder CC, Geisbert TW. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity. The Journal of Infectious Diseases. PMID 32022850 DOI: 10.1093/Infdis/Jiz613 |
0.447 |
|
| 2019 |
Kalodimou G, Veit S, Jany S, Kalinke U, Broder CC, Sutter G, Volz A. A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice. Viruses. 12. PMID 31878180 DOI: 10.3390/v12010026 |
0.365 |
|
| 2019 |
Mire CE, Chan YP, Borisevich V, Cross RW, Yan L, Agans KN, Dang HV, Veesler D, Fenton KA, Geisbert TW, Broder CC. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection. The Journal of Infectious Diseases. PMID 31686101 DOI: 10.1093/Infdis/Jiz515 |
0.514 |
|
| 2019 |
Seifert SN, Letko MC, Bushmaker T, Laing ED, Saturday G, Meade-White K, van Doremalen N, Broder CC, Munster VJ. Rousettus aegyptiacus Bats Do Not Support Productive Nipah Virus Replication. The Journal of Infectious Diseases. PMID 31682727 DOI: 10.1093/infdis/jiz429 |
0.487 |
|
| 2019 |
Dovih P, Laing ED, Chen Y, Low DHW, Ansil BR, Yang X, Shi Z, Broder CC, Smith GJD, Linster M, Ramakrishnan U, Mendenhall IH. Filovirus-reactive antibodies in humans and bats in Northeast India imply zoonotic spillover. Plos Neglected Tropical Diseases. 13: e0007733. PMID 31671094 DOI: 10.1371/Journal.Pntd.0007733 |
0.358 |
|
| 2019 |
Dang HV, Chan YP, Park YJ, Snijder J, Da Silva SC, Vu B, Yan L, Feng YR, Rockx B, Geisbert TW, Mire CE, Broder CC, Veesler D. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nature Structural & Molecular Biology. PMID 31570878 DOI: 10.1038/S41594-019-0308-9 |
0.447 |
|
| 2019 |
Laing ED, Navaratnarajah CK, Cheliout Da Silva S, Petzing SR, Xu Y, Sterling SL, Marsh GA, Wang LF, Amaya M, Nikolov DB, Cattaneo R, Broder CC, Xu K. Structural and functional analyses reveal promiscuous and species specific use of ephrin receptors by Cedar virus. Proceedings of the National Academy of Sciences of the United States of America. PMID 31548390 DOI: 10.1073/Pnas.1911773116 |
0.338 |
|
| 2019 |
Stantchev TS, Zack-Taylor A, Mattson N, Strebel K, Broder CC, Clouse KA. Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages. Viruses. 11. PMID 31547585 DOI: 10.3390/V11100889 |
0.306 |
|
| 2019 |
Laing ED, Sterling SL, Weir DL, Beauregard CR, Smith IL, Larsen SE, Wang LF, Snow AL, Schaefer BC, Broder CC. Enhanced Autophagy Contributes to Reduced Viral Infection in Black Flying Fox Cells. Viruses. 11. PMID 30875748 DOI: 10.3390/v11030260 |
0.415 |
|
| 2018 |
Laing ED, Amaya M, Navaratnarajah CK, Feng YR, Cattaneo R, Wang LF, Broder CC. Rescue and characterization of recombinant cedar virus, a non-pathogenic Henipavirus species. Virology Journal. 15: 56. PMID 29587789 DOI: 10.1186/S12985-018-0964-0 |
0.474 |
|
| 2018 |
Peel AJ, Baker KS, Hayman DTS, Broder CC, Cunningham AA, Fooks AR, Garnier R, Wood JLN, Restif O. Support for viral persistence in bats from age-specific serology and models of maternal immunity. Scientific Reports. 8: 3859. PMID 29497106 DOI: 10.1038/s41598-018-22236-6 |
0.356 |
|
| 2018 |
Colling A, Lunt R, Bergfeld J, McNabb L, Halpin K, Juzva S, Newberry K, Morrissy C, Loomes C, Warner S, Diallo I, Kirkland P, Broder CC, Carlile G, Loh MH, et al. A network approach for provisional assay recognition of a Hendra virus antibody ELISA: test validation with low sample numbers from infected horses. Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc. 1040638718760102. PMID 29463198 DOI: 10.1177/1040638718760102 |
0.319 |
|
| 2016 |
Pickering BS, Hardham JM, Smith G, Weingartl ET, Dominowski PJ, Foss DL, Mwangi D, Broder CC, Roth JA, Weingartl HM. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response. Vaccine. PMID 27544586 DOI: 10.1016/j.vaccine.2016.08.028 |
0.379 |
|
| 2016 |
Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy. Scientific Reports. 6: 30916. PMID 27484128 DOI: 10.1038/Srep30916 |
0.373 |
|
| 2016 |
Broder CC, Weir DL, Reid PA. Hendra virus and Nipah virus animal vaccines. Vaccine. PMID 27154393 DOI: 10.1016/j.vaccine.2016.03.075 |
0.473 |
|
| 2016 |
Peel AJ, Field HE, Reid PA, Plowright RK, Broder CC, Skerratt LF, Hayman DT, Restif O, Taylor M, Martin G, Crameri G, Smith I, Baker M, Marsh GA, Barr J, et al. The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'. Infection Ecology & Epidemiology. 6: 31658. PMID 27151273 |
0.406 |
|
| 2016 |
Borisevich V, Lee B, Hickey A, DeBuysscher B, Broder CC, Feldmann H, Rockx B. Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo. The Journal of Infectious Diseases. 213: 448-55. PMID 26357909 DOI: 10.1093/Infdis/Jiv449 |
0.376 |
|
| 2015 |
Xu K, Chan YP, Bradel-Tretheway B, Akyol-Ataman Z, Zhu Y, Dutta S, Yan L, Feng Y, Wang LF, Skiniotis G, Lee B, Zhou ZH, Broder CC, Aguilar HC, Nikolov DB. Crystal Structure of the Pre-fusion Nipah Virus Fusion Glycoprotein Reveals a Novel Hexamer-of-Trimers Assembly. Plos Pathogens. 11: e1005322. PMID 26646856 DOI: 10.1371/Journal.Ppat.1005322 |
0.311 |
|
| 2014 |
Chowdhury S, Khan SU, Crameri G, Epstein JH, Broder CC, Islam A, Peel AJ, Barr J, Daszak P, Wang LF, Luby SP. Serological evidence of henipavirus exposure in cattle, goats and pigs in Bangladesh. Plos Neglected Tropical Diseases. 8: e3302. PMID 25412358 DOI: 10.1371/journal.pntd.0003302 |
0.361 |
|
| 2014 |
Geisbert TW, Mire CE, Geisbert JB, Chan YP, Agans KN, Feldmann F, Fenton KA, Zhu Z, Dimitrov DS, Scott DP, Bossart KN, Feldmann H, Broder CC. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody. Science Translational Medicine. 6: 242ra82. PMID 24964990 DOI: 10.1126/Scitranslmed.3008929 |
0.765 |
|
| 2014 |
Weir DL, Laing ED, Smith IL, Wang LF, Broder CC. Host cell virus entry mediated by Australian bat lyssavirus G envelope glycoprotein occurs through a clathrin-mediated endocytic pathway that requires actin and Rab5. Virology Journal. 11: 40. PMID 24576301 DOI: 10.1186/1743-422X-11-40 |
0.453 |
|
| 2014 |
Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, Frazer L, Huang JA, Edwards N, Wareing M, Elhay M, Hashmi Z, Bingham J, Yamada M, Johnson D, ... ... Broder CC, et al. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health. Emerging Infectious Diseases. 20: 372-9. PMID 24572697 DOI: 10.3201/eid2003.131159 |
0.3 |
|
| 2014 |
Weir DL, Annand EJ, Reid PA, Broder CC. Recent observations on Australian bat lyssavirus tropism and viral entry. Viruses. 6: 909-26. PMID 24556791 DOI: 10.3390/v6020909 |
0.462 |
|
| 2014 |
Mire CE, Geisbert JB, Agans KN, Feng YR, Fenton KA, Bossart KN, Yan L, Chan YP, Broder CC, Geisbert TW. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge. Journal of Virology. 88: 4624-31. PMID 24522928 DOI: 10.1128/Jvi.00005-14 |
0.731 |
|
| 2014 |
McNabb L, Barr J, Crameri G, Juzva S, Riddell S, Colling A, Boyd V, Broder C, Wang LF, Lunt R. Henipavirus microsphere immuno-assays for detection of antibodies against Hendra virus. Journal of Virological Methods. 200: 22-8. PMID 24508193 DOI: 10.1016/J.Jviromet.2014.01.010 |
0.478 |
|
| 2014 |
Elshabrawy HA, Fan J, Haddad CS, Ratia K, Broder CC, Caffrey M, Prabhakar BS. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. Journal of Virology. 88: 4353-65. PMID 24501399 DOI: 10.1128/Jvi.03050-13 |
0.341 |
|
| 2014 |
Baker KS, Suu-Ire R, Barr J, Hayman DT, Broder CC, Horton DL, Durrant C, Murcia PR, Cunningham AA, Wood JL. Viral antibody dynamics in a chiropteran host. The Journal of Animal Ecology. 83: 415-28. PMID 24111634 DOI: 10.1111/1365-2656.12153 |
0.352 |
|
| 2014 |
Luby SP, Broder CC. Paramyxoviruses: Henipaviruses Viral Infections of Humans: Epidemiology and Control. 519-536. DOI: 10.1007/978-1-4899-7448-8_22 |
0.548 |
|
| 2013 |
Xu K, Rockx B, Xie Y, DeBuysscher BL, Fusco DL, Zhu Z, Chan YP, Xu Y, Luu T, Cer RZ, Feldmann H, Mokashi V, Dimitrov DS, Bishop-Lilly KA, Broder CC, et al. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody. Plos Pathogens. 9: e1003684. PMID 24130486 DOI: 10.1371/Journal.Ppat.1003684 |
0.426 |
|
| 2013 |
Bossart KN, Fusco DL, Broder CC. Paramyxovirus entry. Advances in Experimental Medicine and Biology. 790: 95-127. PMID 23884588 DOI: 10.1007/978-1-4614-7651-1_6 |
0.745 |
|
| 2013 |
Pallister JA, Klein R, Arkinstall R, Haining J, Long F, White JR, Payne J, Feng YR, Wang LF, Broder CC, Middleton D. Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months. Virology Journal. 10: 237. PMID 23867060 DOI: 10.1186/1743-422X-10-237 |
0.422 |
|
| 2013 |
Weir DL, Smith IL, Bossart KN, Wang LF, Broder CC. Host cell tropism mediated by Australian bat lyssavirus envelope glycoproteins. Virology. 444: 21-30. PMID 23849788 DOI: 10.1016/J.Virol.2013.06.016 |
0.741 |
|
| 2013 |
Broder CC, Xu K, Nikolov DB, Zhu Z, Dimitrov DS, Middleton D, Pallister J, Geisbert TW, Bossart KN, Wang LF. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Research. 100: 8-13. PMID 23838047 DOI: 10.1016/J.Antiviral.2013.06.012 |
0.791 |
|
| 2013 |
Broder CC. Passive immunization and active vaccination against hendra and nipah viruses Developments in Biologicals. 135: 125-138. PMID 23689890 DOI: 10.1159/000171017 |
0.436 |
|
| 2013 |
Zhu Z, Prabakaran P, Chen W, Broder CC, Gong R, Dimitrov DS. Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1. Virologica Sinica. 28: 71-80. PMID 23575729 DOI: 10.1007/s12250-013-3313-x |
0.478 |
|
| 2013 |
Quinnan GV, Zhang P, Dong M, Chen H, Feng YR, Lewis M, Broder CC. Neutralizing antibody responses in macaques induced by human immunodeficiency virus type 1 monovalent or trivalent envelope glycoproteins. Plos One. 8: e59803. PMID 23533650 DOI: 10.1371/Journal.Pone.0059803 |
0.364 |
|
| 2013 |
Marsh GA, Virtue ER, Smith I, Todd S, Arkinstall R, Frazer L, Monaghan P, Smith GA, Broder CC, Middleton D, Wang LF. Recombinant Hendra viruses expressing a reporter gene retain pathogenicity in ferrets. Virology Journal. 10: 95. PMID 23521919 DOI: 10.1186/1743-422X-10-95 |
0.436 |
|
| 2012 |
Stantchev TS, Paciga M, Lankford CR, Schwartzkopff F, Broder CC, Clouse KA. Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection. Retrovirology. 9: 97. PMID 23206338 DOI: 10.1186/1742-4690-9-97 |
0.306 |
|
| 2012 |
Xu K, Chan YP, Rajashankar KR, Khetawat D, Yan L, Kolev MV, Broder CC, Nikolov DB. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2. Plos One. 7: e48742. PMID 23144952 DOI: 10.1371/Journal.Pone.0048742 |
0.442 |
|
| 2012 |
Chan YP, Lu M, Dutta S, Yan L, Barr J, Flora M, Feng YR, Xu K, Nikolov DB, Wang LF, Skiniotis G, Broder CC. Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. Journal of Virology. 86: 11457-71. PMID 22915804 DOI: 10.1128/Jvi.01318-12 |
0.356 |
|
| 2012 |
Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Science Translational Medicine. 4: 146ra107. PMID 22875827 DOI: 10.1126/Scitranslmed.3004241 |
0.749 |
|
| 2012 |
Broder CC. Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Current Opinion in Virology. 2: 176-87. PMID 22482714 DOI: 10.1016/j.coviro.2012.02.016 |
0.456 |
|
| 2012 |
Broder CC, Geisbert TW, Xu K, Nikolov DB, Wang LF, Middleton D, Pallister J, Bossart KN. Immunization strategies against henipaviruses. Current Topics in Microbiology and Immunology. 359: 197-223. PMID 22481140 DOI: 10.1007/82_2012_213 |
0.76 |
|
| 2012 |
Geisbert TW, Feldmann H, Broder CC. Animal challenge models of henipavirus infection and pathogenesis. Current Topics in Microbiology and Immunology. 359: 153-77. PMID 22476556 DOI: 10.1007/82_2012_208 |
0.415 |
|
| 2012 |
Steffen DL, Xu K, Nikolov DB, Broder CC. Henipavirus mediated membrane fusion, virus entry and targeted therapeutics. Viruses. 4: 280-308. PMID 22470837 DOI: 10.3390/V4020280 |
0.384 |
|
| 2012 |
Peel AJ, Baker KS, Crameri G, Barr JA, Hayman DT, Wright E, Broder CC, Fernández-Loras A, Fooks AR, Wang LF, Cunningham AA, Wood JL. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. Plos One. 7: e30346. PMID 22253928 DOI: 10.1371/Journal.Pone.0030346 |
0.324 |
|
| 2012 |
Xu K, Broder CC, Nikolov DB. Ephrin-B2 and ephrin-B3 as functional henipavirus receptors. Seminars in Cell & Developmental Biology. 23: 116-23. PMID 22227101 DOI: 10.1016/J.Semcdb.2011.12.005 |
0.439 |
|
| 2012 |
Colgrave ML, Snelling HJ, Shiell BJ, Feng YR, Chan YP, Bossart KN, Xu K, Nikolov DB, Broder CC, Michalski WP. Site occupancy and glycan compositional analysis of two soluble recombinant forms of the attachment glycoprotein of Hendra virus. Glycobiology. 22: 572-84. PMID 22171062 DOI: 10.1093/Glycob/Cwr180 |
0.744 |
|
| 2012 |
Kaku Y, Noguchi A, Marsh GA, Barr JA, Okutani A, Hotta K, Bazartseren B, Fukushi S, Broder CC, Yamada A, Inoue S, Wang LF. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. Journal of Virological Methods. 179: 226-32. PMID 22115786 DOI: 10.1016/j.jviromet.2011.11.003 |
0.36 |
|
| 2011 |
Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, ... ... Broder CC, et al. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge. Science Translational Medicine. 3: 105ra103. PMID 22013123 DOI: 10.1126/Scitranslmed.3002901 |
0.766 |
|
| 2011 |
Hayman DT, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC, Cunningham AA, Wood JL. Antibodies to henipavirus or henipa-like viruses in domestic pigs in Ghana, West Africa. Plos One. 6: e25256. PMID 21966471 DOI: 10.1371/journal.pone.0025256 |
0.368 |
|
| 2011 |
Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge. Vaccine. 29: 5623-30. PMID 21689706 DOI: 10.1016/j.vaccine.2011.06.015 |
0.457 |
|
| 2011 |
Yuan J, Marsh G, Khetawat D, Broder CC, Wang LF, Shi Z. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection. The Journal of General Virology. 92: 2142-52. PMID 21632558 DOI: 10.1099/vir.0.033787-0 |
0.44 |
|
| 2010 |
Chen W, Zhu Z, Liao H, Quinnan GV, Broder CC, Haynes BF, Dimitrov DS. Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope Glycoproteins. Viruses. 2: 547-565. PMID 21755021 DOI: 10.3390/V2020547 |
0.354 |
|
| 2010 |
Khurana B, Zhuang L, Moitra PK, Stantchev TS, Broder CC, Cutler ML, D'Arpa P. Human TOP1 residues implicated in species specificity of HIV-1 infection are required for interaction with BTBD2, and RNAi of BTBD2 in old world monkey and human cells increases permissiveness to HIV-1 infection. Virology Journal. 7: 332. PMID 21092135 DOI: 10.1186/1743-422X-7-332 |
0.358 |
|
| 2010 |
Khetawat D, Broder CC. A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virology Journal. 7: 312. PMID 21073718 DOI: 10.1186/1743-422X-7-312 |
0.531 |
|
| 2010 |
Defang GN, Khetawat D, Broder CC, Quinnan GV. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system. Vaccine. 29: 212-20. PMID 21050901 DOI: 10.1016/J.Vaccine.2010.10.053 |
0.424 |
|
| 2010 |
Dube D, Schornberg KL, Shoemaker CJ, Delos SE, Stantchev TS, Clouse KA, Broder CC, White JM. Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry. Proceedings of the National Academy of Sciences of the United States of America. 107: 16637-42. PMID 20817853 DOI: 10.1073/Pnas.1008509107 |
0.338 |
|
| 2010 |
Rockx B, Bossart KN, Feldmann F, Geisbert JB, Hickey AC, Brining D, Callison J, Safronetz D, Marzi A, Kercher L, Long D, Broder CC, Feldmann H, Geisbert TW. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment. Journal of Virology. 84: 9831-9. PMID 20660198 DOI: 10.1128/Jvi.01163-10 |
0.762 |
|
| 2010 |
Geisbert TW, Daddario-DiCaprio KM, Hickey AC, Smith MA, Chan YP, Wang LF, Mattapallil JJ, Geisbert JB, Bossart KN, Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. Plos One. 5: e10690. PMID 20502528 DOI: 10.1371/Journal.Pone.0010690 |
0.753 |
|
| 2009 |
Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. Plos Pathogens. 5: e1000642. PMID 19888339 DOI: 10.1371/Journal.Ppat.1000642 |
0.786 |
|
| 2009 |
Pallister J, Middleton D, Crameri G, Yamada M, Klein R, Hancock TJ, Foord A, Shiell B, Michalski W, Broder CC, Wang LF. Chloroquine administration does not prevent Nipah virus infection and disease in ferrets. Journal of Virology. 83: 11979-82. PMID 19759137 DOI: 10.1128/JVI.01847-09 |
0.501 |
|
| 2009 |
Blanco JC, Pletneva LM, Wieczorek L, Khetawat D, Stantchev TS, Broder CC, Polonis VR, Prince GA. Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection. Virology Journal. 6: 57. PMID 19442298 DOI: 10.1186/1743-422X-6-57 |
0.384 |
|
| 2009 |
Kaku Y, Noguchi A, Marsh GA, McEachern JA, Okutani A, Hotta K, Bazartseren B, Fukushi S, Broder CC, Yamada A, Inoue S, Wang LF. A neutralization test for specific detection of Nipah virus antibodies using pseudotyped vesicular stomatitis virus expressing green fluorescent protein. Journal of Virological Methods. 160: 7-13. PMID 19433112 DOI: 10.1016/j.jviromet.2009.04.037 |
0.432 |
|
| 2009 |
Chan YP, Yan L, Feng YR, Broder CC. Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery. Methods in Molecular Biology (Clifton, N.J.). 525: 31-58, xiii. PMID 19252850 DOI: 10.1007/978-1-59745-554-1_2 |
0.461 |
|
| 2009 |
Dimitrova D, Choudhry V, Broder CC. Antibody fragment expression and purification. Methods in Molecular Biology (Clifton, N.J.). 525: 491-8, xiii. PMID 19252844 DOI: 10.1007/978-1-59745-554-1_25 |
0.451 |
|
| 2009 |
Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS. Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses. Expert Opinion On Biological Therapy. 9: 355-68. PMID 19216624 DOI: 10.1517/14712590902763755 |
0.41 |
|
| 2009 |
Hickey AC, Broder CC. The mechanism of henipavirus fusion: Examining the relationships between the attachment and fusion glycoproteins Virologica Sinica. 24: 110-120. DOI: 10.1007/s12250-009-3027-2 |
0.41 |
|
| 2008 |
Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, Broder CC. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virology Journal. 5: 137. PMID 19000317 DOI: 10.1186/1743-422X-5-137 |
0.383 |
|
| 2008 |
Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, Wang LF, Dimitrov DS, Broder CC. Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. Journal of Virology. 82: 11398-409. PMID 18799571 DOI: 10.1128/Jvi.02654-07 |
0.709 |
|
| 2008 |
Xu K, Rajashankar KR, Chan YP, Himanen JP, Broder CC, Nikolov DB. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proceedings of the National Academy of Sciences of the United States of America. 105: 9953-8. PMID 18632560 DOI: 10.1073/Pnas.0804797105 |
0.423 |
|
| 2008 |
McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats. Vaccine. 26: 3842-52. PMID 18556094 DOI: 10.1016/J.Vaccine.2008.05.016 |
0.708 |
|
| 2008 |
Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, Alam M, Ruprecht RM, Quinnan G, Jiang S, Montefiori DC, Mascola JR, Broder CC, Haynes BF, Dimitrov DS. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. Journal of Virology. 82: 6869-79. PMID 18480433 DOI: 10.1128/Jvi.00033-08 |
0.401 |
|
| 2008 |
Dube D, Schornberg KL, Stantchev TS, Bonaparte MI, Delos SE, Bouton AH, Broder CC, White JM. Cell adhesion promotes Ebola virus envelope glycoprotein-mediated binding and infection. Journal of Virology. 82: 7238-42. PMID 18448524 DOI: 10.1128/Jvi.00425-08 |
0.454 |
|
| 2008 |
Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. The Journal of Infectious Diseases. 197: 846-53. PMID 18271743 DOI: 10.1086/528801 |
0.722 |
|
| 2008 |
Bossart KN, Tachedjian M, McEachern JA, Crameri G, Zhu Z, Dimitrov DS, Broder CC, Wang LF. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. Virology. 372: 357-71. PMID 18054977 DOI: 10.1016/J.Virol.2007.11.011 |
0.738 |
|
| 2007 |
Mungall BA, Middleton D, Crameri G, Halpin K, Bingham J, Eaton BT, Broder CC. Vertical transmission and fetal replication of Nipah virus in an experimentally infected cat. The Journal of Infectious Diseases. 196: 812-6. PMID 17703410 DOI: 10.1086/520818 |
0.384 |
|
| 2007 |
Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, Gill P, Feng YR, Wang L, Eaton BT, Wang LF, Broder CC. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. Journal of Virology. 81: 5893-901. PMID 17376907 DOI: 10.1128/Jvi.02022-06 |
0.75 |
|
| 2007 |
Choudhry V, Zhang MY, Sidorov IA, Louis JM, Harris I, Dimitrov AS, Bouma P, Cham F, Choudhary A, Rybak SM, Fouts T, Montefiori DC, Broder CC, Quinnan GV, Dimitrov DS. Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodies. Virology. 363: 79-90. PMID 17306322 DOI: 10.1016/J.Virol.2007.01.015 |
0.317 |
|
| 2007 |
Patch JR, Crameri G, Wang LF, Eaton BT, Broder CC. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. Virology Journal. 4: 1. PMID 17204159 DOI: 10.1186/1743-422X-4-1 |
0.402 |
|
| 2007 |
Stantchev TS, Markovic I, Telford WG, Clouse KA, Broder CC. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Research. 123: 178-89. PMID 17030448 DOI: 10.1016/j.virusres.2006.09.004 |
0.353 |
|
| 2006 |
Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. Journal of Virology. 80: 12293-302. PMID 17005664 DOI: 10.1128/Jvi.01619-06 |
0.749 |
|
| 2006 |
Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X, Broder CC, Dimitrov DS. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Expert Review of Anti-Infective Therapy. 4: 57-66. PMID 16441209 DOI: 10.1586/14787210.4.1.57 |
0.484 |
|
| 2006 |
Bossart KN, Broder CC. Developments towards effective treatments for Nipah and Hendra virus infection. Expert Review of Anti-Infective Therapy. 4: 43-55. PMID 16441208 DOI: 10.1586/14787210.4.1.43 |
0.789 |
|
| 2006 |
Zhu Z, Dimitrov AS, Bossart KN, Crameri G, Bishop KA, Choudhry V, Mungall BA, Feng YR, Choudhary A, Zhang MY, Feng Y, Wang LF, Xiao X, Eaton BT, Broder CC, et al. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies. Journal of Virology. 80: 891-9. PMID 16378991 DOI: 10.1128/Jvi.80.2.891-899.2006 |
0.733 |
|
| 2006 |
Eaton BT, Broder CC, Middleton D, Wang LF. Hendra and Nipah viruses: different and dangerous. Nature Reviews. Microbiology. 4: 23-35. PMID 16357858 DOI: 10.1038/nrmicro1323 |
0.414 |
|
| 2005 |
Eaton BT, Broder CC, Wang LF. Hendra and Nipah viruses: pathogenesis and therapeutics. Current Molecular Medicine. 5: 805-16. PMID 16375714 DOI: 10.2174/156652405774962308 |
0.456 |
|
| 2005 |
Bossart KN, Mungall BA, Crameri G, Wang LF, Eaton BT, Broder CC. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virology Journal. 2: 57. PMID 16026621 DOI: 10.1186/1743-422X-2-57 |
0.726 |
|
| 2005 |
Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, Choudhry V, Dimitrov DS, Wang LF, Eaton BT, Broder CC. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proceedings of the National Academy of Sciences of the United States of America. 102: 10652-7. PMID 15998730 DOI: 10.1073/Pnas.0504887102 |
0.779 |
|
| 2005 |
Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. Journal of Virology. 79: 6690-702. PMID 15890907 DOI: 10.1128/Jvi.79.11.6690-6702.2005 |
0.795 |
|
| 2005 |
Quinnan GV, Yu XF, Lewis MG, Zhang PF, Sutter G, Silvera P, Dong M, Choudhary A, Sarkis PT, Bouma P, Zhang Z, Montefiori DC, Vancott TC, Broder CC. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells. Journal of Virology. 79: 3358-69. PMID 15731230 DOI: 10.1128/Jvi.79.6.3358-3369.2005 |
0.44 |
|
| 2004 |
Zhang MY, Xiao X, Sidorov IA, Choudhry V, Cham F, Zhang PF, Bouma P, Zwick M, Choudhary A, Montefiori DC, Broder CC, Burton DR, Quinnan GV, Dimitrov DS. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. Journal of Virology. 78: 9233-42. PMID 15308718 DOI: 10.1128/Jvi.78.17.9233-9242.2004 |
0.332 |
|
| 2004 |
Eaton BT, Wright PJ, Wang LF, Sergeyev O, Michalski WP, Bossart KN, Broder CC. Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor. Archives of Virology. Supplementum. 122-31. PMID 15119767 DOI: 10.1007/978-3-7091-0572-6_10 |
0.766 |
|
| 2004 |
Bossart KN, Broder CC. Viral glycoprotein-mediated cell fusion assays using vaccinia virus vectors. Methods in Molecular Biology (Clifton, N.J.). 269: 309-32. PMID 15114023 DOI: 10.1385/1-59259-789-0:309 |
0.762 |
|
| 2004 |
Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomiç M, Weiss CD, Broder CC, Strebel K, Clouse KA. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood. 103: 1586-94. PMID 14592831 DOI: 10.1182/Blood-2003-05-1390 |
0.373 |
|
| 2003 |
Zhang MY, Shu Y, Phogat S, Xiao X, Cham F, Bouma P, Choudhary A, Feng YR, Sanz I, Rybak S, Broder CC, Quinnan GV, Evans T, Dimitrov DS. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. Journal of Immunological Methods. 283: 17-25. PMID 14659896 DOI: 10.1016/J.Jim.2003.07.003 |
0.316 |
|
| 2003 |
Albu DI, Jones-Trower A, Woron AM, Stellrecht K, Broder CC, Metzger DW. Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins. Journal of Virology. 77: 5589-97. PMID 12719551 DOI: 10.1128/Jvi.77.10.5589-5597.2003 |
0.308 |
|
| 2003 |
Dong M, Zhang PF, Grieder F, Lee J, Krishnamurthy G, VanCott T, Broder C, Polonis VR, Yu XF, Shao Y, Faix D, Valente P, Quinnan GV. Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system. Journal of Virology. 77: 3119-30. PMID 12584337 DOI: 10.1128/Jvi.77.5.3119-3130.2003 |
0.509 |
|
| 2002 |
Bossart KN, Wang LF, Flora MN, Chua KB, Lam SK, Eaton BT, Broder CC. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. Journal of Virology. 76: 11186-98. PMID 12388678 DOI: 10.1128/Jvi.76.22.11186-11198.2002 |
0.785 |
|
| 2002 |
Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, Ryser HJ. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. The Journal of Biological Chemistry. 277: 50579-88. PMID 12218051 DOI: 10.1074/Jbc.M204547200 |
0.311 |
|
| 2002 |
Moulard M, Phogat SK, Shu Y, Labrijn AF, Xiao X, Binley JM, Zhang MY, Sidorov IA, Broder CC, Robinson J, Parren PW, Burton DR, Dimitrov DS. Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. Proceedings of the National Academy of Sciences of the United States of America. 99: 6913-8. PMID 11997472 DOI: 10.1073/pnas.102562599 |
0.34 |
|
| 2001 |
Bossart KN, Wang LF, Eaton BT, Broder CC. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology. 290: 121-35. PMID 11882997 DOI: 10.1006/Viro.2001.1158 |
0.772 |
|
| 2001 |
Stantchev TS, Broder CC. Human immunodeficiency virus type-1 and chemokines: Beyond competition for common cellular receptors Cytokine and Growth Factor Reviews. 12: 219-243. PMID 11325604 DOI: 10.1016/S1359-6101(00)00033-2 |
0.328 |
|
| 2001 |
Earl PL, Sugiura W, Montefiori DC, Broder CC, Lee SA, Wild C, Lifson J, Moss B. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140. Journal of Virology. 75: 645-53. PMID 11134278 DOI: 10.1128/Jvi.75.2.645-653.2001 |
0.399 |
|
| 2000 |
Stantchev TS, Broder CC. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by β-chemokines (RANTES) in primary human macrophages Journal of Infectious Diseases. 182: 68-78. PMID 10882583 DOI: 10.1086/315700 |
0.346 |
|
| 2000 |
Chabot DJ, Broder CC. Substitutions in a homologous region of extracellular loop 2 of CXCR4 and CCR5 alter coreceptor activities for HIV-1 membrane fusion and virus entry. The Journal of Biological Chemistry. 275: 23774-82. PMID 10827088 DOI: 10.1074/Jbc.M003438200 |
0.737 |
|
| 2000 |
Shirley L, Lapham CK, Chen H, King L, Manischewltz J, Romantseva T, Mostowski H, Stantchev TS, Broder CC, Golding H. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1 Journal of Virology. 74: 5016-5023. PMID 10799575 DOI: 10.1128/JVI.74.11.5016-5023.2000 |
0.375 |
|
| 2000 |
Chabot DJ, Chen H, Dimitrov DS, Broder CC. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates. Journal of Virology. 74: 4404-13. PMID 10756055 DOI: 10.1128/Jvi.74.9.4404-4413.2000 |
0.753 |
|
| 1999 |
Broder CC, Earl PL. Recombinant vaccinia viruses: Design, generation, and isolations Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology. 13: 223-245. PMID 10934535 DOI: 10.1385/MB:13:3:223 |
0.446 |
|
| 1999 |
Chabot DJ, Zhang PF, Quinnan GV, Broder CC. Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates. Journal of Virology. 73: 6598-609. PMID 10400757 DOI: 10.1128/Jvi.73.8.6598-6609.1999 |
0.746 |
|
| 1999 |
Sugiura W, Broder CC, Moss B, Earl PL. Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with monomeric and oligomeric human immunodeficiency virus type 1 envelope proteins. Virology. 254: 257-67. PMID 9986792 DOI: 10.1006/Viro.1998.9549 |
0.322 |
|
| 1998 |
Dimitrov DS, Xiao X, Chabot DJ, Broder CC. HIV coreceptors. The Journal of Membrane Biology. 166: 75-90. PMID 9841733 DOI: 10.1007/s002329900450 |
0.665 |
|
| 1998 |
Bazan HA, Alkhatib G, Broder CC, Berger EA. Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates Journal of Virology. 72: 4485-4491. PMID 9557746 |
0.375 |
|
| 1997 |
Broder CC, Collman RG. Chemokine receptors and HIV Journal of Leukocyte Biology. 62: 20-29. PMID 9225988 DOI: 10.1002/Jlb.62.1.20 |
0.382 |
|
| 1997 |
Lee S, Peden K, Dimitrov DS, Broder CC, Manischewitz J, Denisova G, Gershoni JM, Golding H. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody Journal of Virology. 71: 6037-6043. PMID 9223495 |
0.317 |
|
| 1997 |
Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu ZH, Clements JE, Murphey-Corb M, Peiper SC, Parmentier M, Broder CC, Doms RW. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains. Proceedings of the National Academy of Sciences of the United States of America. 94: 4005-10. PMID 9108095 DOI: 10.1073/Pnas.94.8.4005 |
0.324 |
|
| 1997 |
Earl PL, Broder CC, Doms RW, Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein Journal of Virology. 71: 2674-2684. PMID 9060620 DOI: 10.1128/Jvi.71.4.2674-2684.1997 |
0.353 |
|
| 1997 |
Earl PL, Broder CC, Doms RW, Moss B. Epitope map of human immunodeficiency virus type 1 gp41 derived from 47 monoclonal antibodies produced by immunization with oligomeric envelope protein. Journal of Virology. 71: 2674-2684. DOI: 10.1128/jvi.71.4.2674-2684.1997 |
0.346 |
|
| 1996 |
Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1 Science. 272: 1955-1958. PMID 8658171 |
0.325 |
|
| 1996 |
Richardson TM, Stryjewski BL, Broder CC, Hoxie JA, Mascola JR, Earl PL, Doms RW. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein Journal of Virology. 70: 753-762. PMID 8551612 DOI: 10.1128/Jvi.70.2.753-762.1996 |
0.302 |
|
| 1995 |
Broder CC, Berger EA. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages Proceedings of the National Academy of Sciences of the United States of America. 92: 9004-9008. PMID 7568061 DOI: 10.1073/pnas.92.19.9004 |
0.3 |
|
| 1994 |
Broder CC, Kennedy PE, Michaels F, Berger EA. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors Gene. 142: 167-174. PMID 8194748 DOI: 10.1016/0378-1119(94)90257-7 |
0.34 |
|
| 1994 |
Nussbaum O, Broder CC, Berger EA. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation Journal of Virology. 68: 5411-5422. PMID 8057423 |
0.428 |
|
| 1994 |
Broder CC, Earl PL, Long D, Abedon ST, Moss B, Doms RW. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: Oligomer-specific and -sensitive monoclonal antibodies Proceedings of the National Academy of Sciences of the United States of America. 91: 11699-11703. PMID 7972127 DOI: 10.1073/Pnas.91.24.11699 |
0.32 |
|
| 1994 |
Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities Journal of Virology. 68: 3015-3026. PMID 7512157 DOI: 10.1128/Jvi.68.5.3015-3026.1994 |
0.318 |
|
| 1994 |
Earl PL, Broder CC, Long D, Lee SA, Peterson J, Chakrabarti S, Doms RW, Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. Journal of Virology. 68: 3015-3026. DOI: 10.1128/jvi.68.5.3015-3026.1994 |
0.392 |
|
| Show low-probability matches. |